Aéroports de Montréal (ADM) and Biron Health Group have announced the launch of a pilot project to test a new rapid Covid-19 screening process on departing passengers from Montréal–Trudeau International Airport (YUL) in Quebec, Canada.
The antigenic tests will make it possible to carry out certified and rapid tests within 15 minutes.
Go deeper with GlobalData
Initially, this new service will be offered by reservation to passengers who are travelling to France.
The service will also be available to those travelling via Air Canada, the initial partner of the project, Air France, and KLM Royal Dutch Airlines or Air Transat.
This project will commence on 15 December and will last for an initial period of eight weeks.
The antigenic test used by Biron is approved by Health Canada and recognised in France.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIt uses a nasal swab and will be minimally intrusive. The test will be offered at $149.
The airport noted that other destinations could be added to the pilot project.
Biron professionals will be responsible for the screening in a designated area on the departures level of the airport terminal.
ADM Aéroports de Montréal President and CEO said: “The measures deployed as part of the Travel with Confidence programme at YUL such as taking temperatures and setting up health checkpoints at the three entrances to our terminal, have already proven to be effective. However, it is essential that further initiatives are put forward by airports, airlines and public health teams to ensure that travel is resumed.
“The pilot screening test project improves the procedures already in place and represents a decisive step in ensuring the safest possible travel for passengers. The industry must be innovative and adapt to a new reality, and ADM is proud to be contributing to this effort together with its partners.”
Biron Health Group president and CEO Geneviève Biron said: “The pandemic has had unprecedented impacts on our lives, the Québec economy, and even the entire world. While it is essential to maintain and focus on the public health efforts made to control the pandemic, it is also important to pay attention to the recovery of our economy at the same time.
“We are proud to be collaborating in this pilot project and to support our partners in the revival of airport activities and air transport by leveraging our laboratory expertise and the medical and scientific know-how of our professionals.”
